Information Provided By: 
Fly News Breaks for April 1, 2015
VVUS
Apr 1, 2015 | 09:28 EDT
After Vivus announced that it would reduce its sales force to about 100 from about 150, RBC Capital says that the move will hamper the trajectory of the company's anti-obesity drug, Qsymia. The firm says that other companies launching anti-obesity drugs have much larger sales teams. However, it keeps an Outperform rating on VIVUS.
News For VVUS From the Last 2 Days
There are no results for your query VVUS
